ABILITY PHARMA

AbilityPharma is a clinical-stage biopharmaceutical company focused on developing first-in-class fully differentiated oral targeted anticancer compounds that produces autophagy-mediated cytotoxicity selectively in cancer cells... AbilityPharma is a biopharmaceutical company developing new first-in-class candidates to treat cancer. We are focused on autophagy as a new therapeutic strategy to induce cell death selectively in cancer cells. Based on this novel mechanism of action, we are generating a portfolio of new drugs targeting oncological unmet needs... AbilityPharma has an experienced management team with outstanding success in getting drugs approved by both the FDA and the EMA, and licensing them to big-pharma. The company is also supported by a highly-qualified team of advisors, not only in the medical or scientific area, but also with the IP, legal or strategic issues. Together, we build an excellent team to lead our projects to success.

VAT numbers: B65217671

Primary location: Girona Spain